Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review

ConclusionsA growing body of accumulated data suggests that SLND is a safe metastasis-directed therapy option in nodal recurrence after primary treatment. However, to date, high level of evidence is still missing to draw any clinically meaningful conclusion about the oncological impact of SLND on long-term endpoints.Patient summaryWhen imaging identifies exclusive nodal recurrent prostate cancer, surgery directed to the positive lesions is safe and can offer at least a temporary biochemical response. The oncological role assessed by strong clinical endpoints remains uncertain.
Source: European Urology - Category: Urology & Nephrology Source Type: research